Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse.
- Lance H. Leopold
- , Mark S. Berger
- , Su Chun Cheng
- , Jorge E. Cortes-Franco
- , Francis J. Giles
- , Elihu H. Estey
Research output: Contribution to journal › Article › peer-review
12
Link opens in a new tab
Scopus
citations